Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Skin Neoplasms 1 Hematologic Neoplasms 1 COVID-19 1

Interventions

Standard of Care 2 Hydroxychloroquine 2 tocilizumab 1 remdesivir 1 palbociclib 1 ogalvibart 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 Practice Guidelines as Topic 1 Immunoglobulin G 1 Disulfides 1 Blood Specimen Collection 1 Azithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × COVID-19 × Azithromycin × Clear all

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡